Case report: CAR-T cell therapy-induced cardiac tamponade

Case report: CAR-T cell therapy-induced cardiac tamponade

CD19-specific chimeric antigen receptor T (CAR-T) cell therapy has recently been shown to improve the prognosis of refractory diffuse large B-cell lymphoma (DLBCL). However, CAR-T cells may induce numerous adverse events, in particular cytokine release syndrome (CRS) which is frequently associated w...

Full description

Bibliographic Details
Main Authors: Sacha Sarfati, Misa Eugène Norbert, Antoine Hérault, Marion Giry, Jade Makké, Maximilien Grall, Arnaud Savouré, Vincent Camus, Mustafa Alani, Fabienne Tamion, Jean-Baptiste Latouche, Christophe Girault
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
CAR-T cell
pericarditis
cardiac tamponade
pericardial effusion
CRS
ICU
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1132503/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1132503/full

Similar Items